MDM2 Inhibitor Intermediate Synthesis Using a Stable Vilsmeier Reagent
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing processes for preparing the MDM2 inhibitor intermediate 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid (Compound A) are inefficient and lack optimization for scalability and purity.
Innovation Solution
A process involving the use of methoxymethylene-N,N-dimethyliminium methyl sulfate as a bench-stable Vilsmeier reagent for selective in situ activation of a primary alcohol intermediate, combined with specific solvents and bases like KOAc, to prepare the intermediate (DHO), which is further characterized by a crystalline form with a distinct X-ray powder diffraction pattern.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional synthetic routes (e.g., Houghtening route, Kunin route) are used to prepare MDM2 inhibitors, then the target compound can be obtained, but the synthesis involves complex multi-step processes with multiple protection and deprotection steps, resulting in low overall yield and high production cost
Solution Approach 1:
The synthesis route is divided into distinct modular stages: preparing the amidine intermediate, preparing the cyclopropyl carboxylic acid intermediate, and coupling them together. This segmentation allows each stage to be optimized independently and simplifies the overall process planning and execution.
Solution Approach 2:
The patent prepares and characterizes key intermediates (amidine intermediate and cyclopropyl carboxylic acid intermediate) in advance with defined purity requirements before final coupling. This preliminary action ensures that when the final coupling step is performed, the reactants are ready-to-use, eliminating the need for in-process purification and reducing overall process complexity.
2Productivity
If traditional synthetic routes are used, then the MDM2 inhibitor can be synthesized, but multiple protection and deprotection steps are required, increasing the number of synthesis steps and reducing efficiency
Solution Approach 1:
The invention extracts and eliminates the unnecessary protection and deprotection steps from the traditional synthetic routes. By designing the synthesis pathway to proceed without these auxiliary steps, the patent directly reduces the total number of steps and the time required for synthesis while maintaining product purity.
Solution Approach 2:
The synthetic route enables continuous progression through the coupling reaction without interruption for protection/deprotection cycles. The amidine intermediate and cyclopropyl carboxylic acid intermediate can be coupled directly in a continuous manner, maximizing productive reaction time and eliminating wasteful standby periods between steps.
3Manufacturing precision
If conventional purification methods are used during synthesis, then intermediate purity can be maintained, but the number of purification steps increases, complicating the process and reducing yield
Solution Approach 1:
The synthesis method is designed so that the reaction conditions themselves promote the formation of pure intermediates without requiring additional purification interventions. The coupling reaction proceeds in a manner that naturally favors the desired product formation, and the intermediates can be used directly in subsequent steps without separate purification operations.
4Ease of manufacture
If existing synthetic routes are employed, then MDM2 inhibitors can be produced, but the production cost is high due to multiple steps and low yield, making it difficult to achieve cost-effective large-scale production
Solution Approach 1:
The patent optimizes reaction parameters such as solvent selection (acetonitrile, dichloromethane, or toluene), temperature ranges (0°C to room temperature), and reagent ratios to maximize yield at each step. By carefully controlling these parameters, the synthesis achieves high efficiency without requiring expensive additional steps or materials.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process enhances the efficiency and scalability of preparing the intermediate, ensuring high purity and consistency, which is crucial for the synthesis of Compound A.
Implementation Method 1
coupling 20-24 with 15-19, wherein the coupling is performed in the presence of a coupling reagent
Implementation Method 2
in the presence of a base
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention provides commercial processes for preparing 2- ((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-l-((S)-l-(isopropylsulfonyl)-3-methylbutan-2-yl)-3 -m ethyl-2-oxopiperi din-3 -yl)acetic acid as well as intermediates thereof.